AKT1 and neoplasm: In contrast, acquired resistance mechanisms include the activation of compensatory pathways such as FGFR1, MAPK, PI3K/AKT/mTOR, Myc, Hippo, tumor metabolism, and alterations in the TME [16, 66, 67].